Cite
Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders
MLA
Cusmai, R., et al. Rufinamide for the Treatment of Refractory Epilepsy Secondary to Neuronal Migration Disorders. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1105023282&authtype=sso&custid=ns315887.
APA
Cusmai, R., Verrotti, A., Moavero, R., Curatolo, P., Battaglia, D. I., Matricardi, S., Spalice, A., Vigevano, F., Pruna, D., Parisi, P., D, A. A., Di Gennaro, G., Coppola, G., & Battaglia, D. I. (ORCID:0000-0003-0491-4021). (2014). Rufinamide for the treatment of refractory epilepsy secondary to neuronal migration disorders.
Chicago
Cusmai, R, A Verrotti, R Moavero, P Curatolo, Domenica Immacolata Battaglia, S Matricardi, A Spalice, et al. 2014. “Rufinamide for the Treatment of Refractory Epilepsy Secondary to Neuronal Migration Disorders.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1105023282&authtype=sso&custid=ns315887.